Star Combo Pharma Ltd (S66) — Cash Flow Reinvestment Rate
Star Combo Pharma Ltd (S66) has a Cash Flow Reinvestment Rate of 0.51x as of December 2025, reinvesting AU$295.53K (capex AU$295.53K ) from operating cash flow of AU$575.23K. Check Star Combo Pharma Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Star Combo Pharma Ltd Cash Flow Reinvestment Rate (2016–2025)
Historical reinvestment intensity for Star Combo Pharma Ltd across 6 annual periods. Explore Star Combo Pharma Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Star Combo Pharma Ltd (2016–2025)
Year-by-year capital reinvestment analysis for Star Combo Pharma Ltd. For live market cap and broader valuation context, see Star Combo Pharma Ltd stock valuation.
| Year | Reinvestment Rate | Total Reinvested (AUD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.03x | AU$393.72K | AU$11.94 Million | AU$393.72K | ▼ -99.0% |
| 2023 | 3.17x | AU$5.96 Million | AU$1.88 Million | AU$2.73 Million | ▼ -97.6% |
| 2022 | 130.24x | AU$11.35 Million | AU$87.11K | AU$7.29 Million | ▲ +192.1% |
| 2021 | 44.59x | AU$14.78 Million | AU$331.53K | AU$7.26 Million | ▲ +15817.9% |
| 2017 | 0.28x | AU$261.13K | AU$932.20K | AU$261.13K | ▼ -68.3% |
| 2016 | 0.88x | AU$1.15 Million | AU$1.30 Million | AU$1.15 Million | — |